METROPOLIS

METROPOLIS HEALTHCARE

Mid Cap BSE: 542650 NSE: METROPOLIS
₹1478.65
2.1 (0.14%)
As on 04 December, 2022 | 14:16

Metropolis Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in METROPOLIS HEALTHCARE

Start SIP

Metropolis Healthcare Share Price

Metropolis Healthcare Share Returns

  • Over 1 Month -15.17%
  • Over 3 Month 5.4%
  • Over 6 Month -6.17%
  • Over 1 Year -53.88%

Metropolis Healthcare Key Statistics

P/E Ratio 48.9
PEG Ratio -1.3
Market Cap Cr 7,572
Price to Book Ratio 8.5
EPS 35.3
Dividend 0.5
Relative Strength Index 42.75
Money Flow Index 28.08
MACD Signal -30.85
Average True Range 46.95

Metropolis Healthcare Investment Rating

  • Master Rating:
  • Metropolis Healthcare has an operating revenue of Rs. 1,179.16 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 24% is great, ROE of 24% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 98 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 280257218212242264238
Operating Expenses Qtr Cr 205196172164172186158
Operating Profit Qtr Cr 75614648707880
Depreciation Qtr Cr 20201212121111
Interest Qtr Cr 7854252
Tax Qtr Cr 137109152215
Net Profit Qtr Cr 38286325446094

Metropolis Healthcare Technicals

EMA & SMA

Current Price
1478.65
2.1 (0.14%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1503.04
  • 50 Day
  • 1527.07
  • 100 Day
  • 1574.4
  • 200 Day
  • 1762.87
  • 20 Day
  • 1516.98
  • 50 Day
  • 1548.44
  • 100 Day
  • 1505.37
  • 200 Day
  • 1707.32

Metropolis Healthcare Resistance and Support

PIVOT
₹1471.29
Resistance
First Resistance 1487.27
Second Resistance 1497.99
Third Resistance 1513.97
RSI 42.75
MFI 28.08
MACD Single Line -30.85
MACD -32.38
Support
First Resistance 1460.57
Second Resistance 1444.59
Third Resistance 1433.87

Metropolis Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 190,685 8,950,754 46.94
Week 164,518 7,704,359 46.83
1 Month 313,125 10,176,566 32.5
6 Month 309,011 9,854,372 31.89

Metropolis Healthcare Result Highlights

Metropolis Healthcare Synopsis

NSE-Medical-Services

Metropolis Healthcar is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1117.13 Cr. and Equity Capital is Rs. 10.23 Cr. for the Year ended 31/03/2022. Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798.
Market Cap 7,572
Sales 967
Shares in Float 2.56
No of funds 200
Yield 0.54
Book Value 9.18
U/D Vol ratio 1.1
LTDebt / Equity 19
Alpha -0.33
Beta 0.94

Metropolis Healthcare

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 49.76%49.79%49.79%
Mutual Funds 10.93%12.76%14.14%
Insurance Companies 0.95%1.09%1.18%
Foreign Portfolio Investors 25.57%23.2%21.91%
Financial Institutions/ Banks
Individual Investors 9.45%9.26%9.14%
Others 3.34%3.9%3.84%

Metropolis Healthcare Management

Name Designation
Dr. Sushil Kanubhai Shah Chairman & Executive Director
Mrs. Ameera Sushil Shah Managing Director
Mr. Hemant Sachdev Non Exe.Non Ind.Director
Mr. Vivek Gambhir Ind. Non-Executive Director
Mr. Sanjay Bhatnagar Ind. Non-Executive Director
Mr. Milind Shripad Sarwate Ind. Non-Executive Director
Ms. Anita Ramachandran Ind. Non-Executive Director

Metropolis Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Metropolis Healthcare Corporate Action

Date Purpose Remarks
2022-11-08 Quarterly Results
2022-08-10 Quarterly Results
2022-07-18 Others Inter alia, to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 31, 2022. per share(400%)Interim Dividend
2022-05-24 Audited Results
2022-02-11 Quarterly Results & Interim Dividend
Date Purpose Remarks
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 26133
Kotak Equity Arbitrage Fund Growth 22082
Aditya Birla Sun Life Flexi Cap Fund Growth 16422
ICICI Prudential Equity Arbitrage Fund Regular Growth 10891
UTI Mastershare Unit Regular Plan Payout Inc Dist cum Cap Wdrl 10878

Metropolis Healthcare FAQs

What is Share Price of Metropolis Healthcare ?

Metropolis Healthcare share price is ₹1478 As on 04 December, 2022 | 14:02

What is the Market Cap of Metropolis Healthcare ?

The Market Cap of Metropolis Healthcare is ₹7571.6 Cr As on 04 December, 2022 | 14:02

What is the P/E ratio of Metropolis Healthcare ?

The P/E ratio of Metropolis Healthcare is 48.9 As on 04 December, 2022 | 14:02

What is the PB ratio of Metropolis Healthcare ?

The PB ratio of Metropolis Healthcare is 8.5 As on 04 December, 2022 | 14:02

Q2FY23